BEYONDSPRING INC.

(BYSI)
  Bericht
Realtime-Estimate Cboe BZX  -  18:00 28.06.2022
1.410 USD   -1.40%
13.06.BeyondSpring Inc. gibt den Rücktritt von Führungskräften mit Wirkung zum 9. Juni 2022 bekannt
CI
09.06.BeyondSpring Inc. gibt den Rücktritt von Gordon L. Schooley als Chief Regulatory Officer bekannt
CI
22.04.BeyondSpring Finanzvorstand Elizabeth Czerepak tritt zurück
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über BEYONDSPRING INC.
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 2500 Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell Small Cap Comp Growth Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 2000 Dynamic Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 2500 Growth Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 2000 Growth Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 2000 Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 3000 Growth Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 3000E Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 3000E Growth Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell 3000 Index
24.06.BEYONDSPRING INC.(NASDAQCM : BYSI) dropped from Russell Small Cap Completeness Index
13.06.BeyondSpring Inc. Announces Executive Resignations, with Effect from June 9, 2022
09.06.BeyondSpring Inc. Announces Resignation of Gordon L. Schooley as Chief Regulatory Offic..
27.05.BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSC..
28.04.BeyondSpring Announces Three Poster Presentations at the American Society of Clinical O..
22.04.BeyondSpring Chief Financial Officer Elizabeth Czerepak Resigns
22.04.Elizabeth Czerepak Resigns as Executive Vice President of BeyondSpring Inc
22.04.Elizabeth Czerepak Resigns as Chief Financial Officer of BeyondSpring Inc
14.04.BeyondSpring Files 2021 Annual Report on Form 20-F
14.04.BEYONDSPRING : Corporate Presentation
14.04.TRANSCRIPT : BeyondSpring Inc., Q4 2021 Earnings Call, Apr 14, 2022
14.04.Earnings Flash (BYSI) BEYONDSPRING Posts Q4 Revenue $1.4M
14.04.BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides ..
14.04.BeyondSpring Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
08.04.BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a ..
11.01.BEYONDSPRING : Announces Organizational Streamlining - Form 6-K
11.01.BeyondSpring to Reduce US Workforce by 35% to Cut Costs
11.01.BeyondSpring Announces Organizational Streamlining
11.01.BeyondSpring Pharmaceuticals Announces Organizational Streamlining
04.01.NORTH AMERICAN MORNING BRIEFING : Stocks to Extend -2-
03.01.BEYONDSPRING : Corporate Presentation
2021BEYONDSPRING : Announces Third Quarter 2021 Financial Results and Provides a Corporate Upd..
2021Earnings Flash (BYSI) BEYONDSPRING Reports Q3 Revenue $337,000
2021BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Up..
2021BeyondSpring Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
2021Beyondspring pharmaceuticals announces new clinical data confirming plinabulin's fast o..
2021BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin's Fast O..
2021BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s F..
2021BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgra..
2021NORTH AMERICAN MORNING BRIEFING : Dow Futures Jump -2-
2021NORTH AMERICAN MORNING BRIEFING : Oil Rises, Stock -3-
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021Health Care Stocks Holding Up After Market Reversal Wednesday
2021Top Midday Decliners
2021Health Care Stocks Helping Lead Wednesday Markets Higher
2021BeyondSpring Shares Plunge After FDA Drug Rejection, HC Wainwright Downgrade
2021BeyondSpring Shares Plummet After FDA Rejects Plinabulin
2021Health Care Stocks Edge Higher Premarket Wednesday
2021Health Care
2021BeyondSpring's Plinabulin New Drug Application for Chemotherapy-Induced Neutropenia Rej..
2021BEYONDSPRING : FDA Rejects Plinabulin in Chemotherapy-Induced Neutropenia
2021BEYONDSPRING : Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabul..
2021BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabu..
2021BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabu..
2021NORTH AMERICAN MORNING BRIEFING : -3-
2021BEYONDSPRING : Corporate Presentation
2021BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Confe..
2021BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Confe..
2021BeyondSpring Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Confere..
2021BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors - Form 6-..
2021BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
2021BeyondSpring Appoints Mark Santos to its Board of Directors
2021BEYONDSPRING : Initiates Mid-Stage Plinabulin Combo Trial in Lung Cancer Patients
2021BEYONDSPRING : Announces First Patient Treated in Phase 2 Study with Plinabulin Combined w..
2021BeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined ..
2021BEYONDSPRING : Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabu..
2021Beyondspring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinab..
2021BEYONDSPRING : Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Pli..
2021BEYONDSPRING : Shares Extend Losses in Afternoon Trading Following Plinabulin Phase 3 Data
2021BEYONDSPRING : Plinabulin Phase 3 Study Meets Primary Endpoint; Shares Drop on Speculation..
2021Top Midday Decliners
2021TRANSCRIPT : BeyondSpring Inc. - Special Call
2021BEYONDSPRING : Says Plinabulin Phase 3 Study Meets Primary Endpoint - Shares Slip Premarke..
2021BEYONDSPRING : Dublin-3 (bpi-2358-103)
2021BEYONDSPRING : Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Pli..
1  2  3  4  5  6Weiter